Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies-Reference-Cited by-同舟云学术

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

Published:2017-01-20 Issue:4 Volume:37 Page:514-528
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Di Maio Velia C.¹,Cento Valeria¹,Lenci Ilaria²,Aragri Marianna¹,Rossi Piera²,Barbaliscia Silvia¹,Melis Michela³,Verucchi Gabriella⁴,Magni Carlo F.⁵,Teti Elisabetta⁶,Bertoli Ada¹,Antonucci FrancescoPaolo¹,Bellocchi Maria C.¹,Micheli Valeria⁷,Masetti Chiara²,Landonio Simona⁵,Francioso Simona²,Santopaolo Francesco²,Pellicelli Adriano M.⁸,Calvaruso Vincenza⁹,Gianserra Laura¹⁰,Siciliano Massimo¹¹,Romagnoli Dante¹²,Cozzolongo Raffaele¹³,Grieco Antonio¹¹,Vecchiet Jacopo¹⁴,Morisco Filomena¹⁵,Merli Manuela¹⁶,Brancaccio Giuseppina¹⁷,Di Biagio Antonio¹⁸,Loggi Elisabetta¹⁹,Mastroianni Claudio M.²⁰,Pace Palitti Valeria²¹,Tarquini Pierluigi²²,Puoti Massimo²³,Taliani Gloria²⁴,Sarmati Loredana⁶,Picciotto Antonino²⁵,Vullo Vincenzo²⁶,Caporaso Nicola¹⁵,Paoloni Maurizio²⁷,Pasquazzi Caterina¹⁰,Rizzardini Giuliano⁵²⁸,Parruti Giustino²⁹,Craxì Antonio⁹,Babudieri Sergio³,Andreoni Massimo⁶,Angelico Mario²,Perno Carlo F.¹,Ceccherini-Silberstein Francesca¹,

Affiliation:

1. Department of Experimental Medicine and Surgery; University of Rome Tor Vergata; Rome Italy

2. Hepatology Unit; University Hospital of Rome Tor Vergata; Rome Italy

3. Infectious Diseases Unit; University of Sassari; Sassari Italy

4. Infection Disease Unit; Policlinico S. Orsola-Malpighi; Bologna Italy

5. Division of Infectious Disease; Hospital Sacco of Milan; Milan Italy

6. Infectious Diseases; University Hospital of Rome Tor Vergata; Rome Italy

7. Unit of Microbiology; Hospital Sacco of Milan; Milan Italy

8. Liver Disease Unit, Department of Liver Transplantation; San Camillo Forlanini Hospital; Rome Italy

9. Gastroenterology; “P. Giaccone” University Hospital; Palermo Italy

10. Infectious Diseases; Sant'Andrea Hospital - Sapienza University of Rome; Rome Italy

11. Gastroenterology; Catholic University of Rome; Rome Italy

12. Department of Biomedical, Metabolic and Neural Sciences; University of Modena and Reggio Emilia; Modena Italy

13. Department of Gastroenterology; Scientific Institute for Digestive Disease “Saverio de Bellis” Hospital; Castellana Grotte; Bari Italy

14. Infectious Disease Clinic; Hospital of Chieti; Chieti Italy

15. Gastroenterology; Department of Clinical Medicine and Surgery; University of Naples “Federico II”; Naples Italy

16. Gastroenterology; Department of Clinical Medicine; Sapienza University of Rome; Rome Italy

17. Infectious Diseases and Viral Hepatitis Unit; Second University; Naples Italy

18. Infectious Diseases Unit; Department of Social Health (DISSAL) of the University of Genoa; IRCCS S. Martino-IST; Genoa Italy

19. Department of Medical and Surgical Sciences; University of Bologna; Bologna Italy

20. Department of Public Health and Infectious Diseases; Sapienza University; Polo Pontino; Latina Italy

21. Hepatology Unit; Pescara General Hospital; Pescara Italy

22. Infectious Disease; Hospital “G. Mazzini”; Teramo Italy

23. Department of Infectious Diseases; Hospital Niguarda Ca'Granda; Milan Italy

24. Infectious and Tropical Diseases Unit; Department of Clinical Medicine; Sapienza University of Rome; Rome Italy

25. Department of Internal Medicine; Gastroenterology Unit; University of Genova; Genoa Italy

26. Department of Public Health and Infectious Diseases; Sapienza University of Rome; Rome Italy

27. Infectious Disease Unit; Avezzano General Hospital; Avezzano Italy

28. School of Clinical Medicine; Faculty of Health Science University of the Witwatersrand; Johannesburg South Africa

29. Infectious Disease Unit; Pescara General Hospital; Pescara Italy

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Aviralia Foundation

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13327/fullpdf

Reference41 articles.

1. EASL Recommendations on Treatment of Hepatitis C J Hepatol 2017 66 153 194

2. Hepatitis C Guidance: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C http://www.hcvguidelines.org

3. Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+);Leroy;Hepatology,2016

4. Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir;Krishnan;Antimicrob Agents Chemother,2015

5. Simeprevir plus sofosbuvir (12 and 8 weeks) in HCV genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3. Randomized study;Kwo;Hepatology,2016

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

3. Study of drug resistance-associated genetic mutations, and phylo-genetic analysis of HCV in the Province of Sindh, Pakistan;Scientific Reports;2023-07-27

4. Host Versus Virus: The Genetics in HCV Infection Leading to Treatment;Hepatitis C - Recent Advances;2023-02-17

5. Viral Fitness, Population Complexity, Host Interactions, and Resistance to Antiviral Agents;Current Topics in Microbiology and Immunology;2023